[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
[ Tue, Jan 02nd 2024 ]: WOPRAI
Stephen Baxter Upgraded (UHS) to Buy and Held Target at $177 on, Jan 2nd, 2024
- 🞛 This publication is a summary or evaluation of another publication
Stephen Baxter of Wells Fargo, Upgraded "Universal Health Services, Inc." (UHS) to Buy and Held Target at $177 on, Jan 2nd, 2024.
Stephen has made no other calls on UHS in the last 4 months.
There are 4 other peers that have a rating on UHS. Out of the 4 peers that are also analyzing UHS, 2 agree with Stephen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Calvin Sternick of "JP Morgan" Maintained at Hold with Decreased Target to $144 on, Friday, November 17th, 2023
- Steven Valiquette of "Barclays" Maintained at Hold and Held Target at $142 on, Thursday, September 21st, 2023
These are the ratings of the 2 analyists that currently disagree with Stephen
- Jamie Perse of "Goldman Sachs" Upgraded from Strong Sell to Strong Buy on, Monday, December 11th, 2023
- Sarah James of "Cantor Fitzgerald" Reiterated at Sell and Held Target at $148 on, Thursday, September 14th, 2023